AQST vs AMPH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AMPH Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amphastar Pharmaceuticals, Inc. (AMPH) driven by superior Valuation, Growth & Margin, Momentum & Technical while AQST counters with relative strength in Options & Structure. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus AMPH at 10.5x Forward P/E and 18.7% operating margin (+8.2% YoY). In options structure, AQST sits in BREAKDOWN (64th %ile IV; Dealer Gamma Walls on Pro) against AMPH sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | AQST Revenue | AMPH Revenue | AQST Op. Margin | AMPH Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $50M | $770M | -89.6% | 13.2% | AMPH |
| Q4 '25 | $50M | $730M | -221.6% | 19.4% | AMPH |
| Q1 '26 | $60M | $680M | -29.1% | 8.0% | AMPH |
| Q2 '26 | $60M | $740M | -59.5% | 21.6% | AMPH |
| Q3 '26 | $30M | $830M | -191.5% | 24.5% | AMPH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AQST | AMPH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $465.7M | $1.2B | Larger Scale | AMPH |
| Trailing P/E Ratio Valuation | N/M | 12.9x | Lower Multiple | AMPH |
| Forward P/E Ratio Valuation | N/M | 10.5x | Lower Multiple | AMPH |
| Revenue Growth (YoY) Growth | -41.0% | +8.2% | Higher Growth | AMPH |
| Operating Margin (TTM) Profitability | -114.1% | 18.7% | Higher Margin | AMPH |
| Net Profit Margin Profitability | -162.3% | 13.3% | Higher Margin | AMPH |
| Return on Equity (ROE) Capital Efficiency | 0.0% | 12.4% | Higher ROE | AMPH |
| 52-Week Range Position Momentum | 14% ($3โ$7) | 81% ($17โ$31) | Stronger Trend | AMPH |
| Beta / 30D Volatility Risk Regime | 0.89ฮฒ ยท 56% Vol | 0.07ฮฒ ยท 37% Vol | Lower Realized Risk | AMPH |
| Unified Institutional Score Composite Signal | 62.9 / 100 (BUY) | 48.8 / 100 (HOLD) | Higher Composite | AQST |